MICA · CARE LEARNING NOTES
Observe, keep care safe and communicate
An injectable corticosteroid requires observation beyond the infusion: glucose, infection status, cardiovascular balance and behaviour. This adult guide supports a medically validated prescription and highlights changes requiring prompt communication.
Check the methylprednisolone formulation
The document used is the UK SmPC for Solu-Medrone 500 mg for injection, Pfizer, methylprednisolone sodium succinate. This is not a depot methylprednisolone acetate suspension. Check pack, vial, formulation, prescribed route and label without transferring instructions from another strength. This reference does not confirm the product’s Algerian status; technical instructions depend on the exact local product validated by pharmacy.
[1]Establish risks before treatment
Review diabetes, hypertension, heart failure, possible infection, psychiatric history and concomitant medicines, including anti-inflammatory drugs or treatments affecting fluid and electrolyte balance. Check that the prescriber has relevant information and requested investigations are available. Infection may worsen or become less apparent under corticosteroids: normal temperature alone is insufficient reassurance. Exposure to chickenpox or measles requires prompt advice.
[1]Include physical and psychological findings
Monitor observations and glucose as prescribed and communicate trends. Dyspnoea, chest pain, arrhythmia or faintness require immediate assessment. A severe acute reaction during administration requires immediate interruption of the suspected product and emergency escalation under protocol. Ask about sleep and mood as well. Unusual agitation, confusion, marked euphoria, psychotic symptoms or suicidal thoughts require urgent advice; these can develop early and must not be dismissed.
[1][2]Agitation, marked insomnia or unusual thoughts during corticosteroid treatment warrant clinical communication even with reassuring vital signs. Combine this with glucose, blood pressure and infection monitoring under the prescribed plan. Explain to the patient and relatives which changes should be reported.
- Record the timing between treatment initiation and mental or physical changes.
Arrange handover without independent treatment changes
Record product, administration, tolerability, results and symptoms reported by the patient or carers. Check the follow-on prescription and contact instructions. Patients must not independently alter, abruptly stop or restart corticosteroids. An alert triggers medical reassessment, consideration of other possible causes and a context-specific decision.
[1][2]A learning situation
FICTIONAL SITUATION · REFLECTION WITHOUT A SCORE
Fictional situation: after treatment, a patient barely sleeps and becomes unusually elated; the family reports a clear change from usual behaviour.
Should assessment wait until the next appointment?
References and scope
Original documentary teaching summary for adult care. Procedures and medicines depend on professional competence, prescription and institutional procedures. International references do not establish an Algerian protocol. Independent human scientific review remains to be confirmed.